Rathbones Group PLC Trims Stake in Apyx Medical Co. (NASDAQ:APYX)

Rathbones Group PLC reduced its holdings in shares of Apyx Medical Co. (NASDAQ:APYX) by 59.7% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 101,334 shares of the company’s stock after selling 150,000 shares during the period. Rathbones Group PLC owned about 0.27% of Apyx Medical worth $160,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in APYX. Kingsview Wealth Management LLC increased its holdings in Apyx Medical by 8.7% during the fourth quarter. Kingsview Wealth Management LLC now owns 135,245 shares of the company’s stock valued at $214,000 after buying an additional 10,800 shares during the last quarter. Raymond James Financial Inc. purchased a new stake in shares of Apyx Medical in the fourth quarter worth $134,000. Commonwealth Equity Services LLC increased its stake in shares of Apyx Medical by 3.0% in the fourth quarter. Commonwealth Equity Services LLC now owns 527,061 shares of the company’s stock worth $833,000 after purchasing an additional 15,500 shares in the last quarter. Royce & Associates LP increased its stake in shares of Apyx Medical by 1.3% in the fourth quarter. Royce & Associates LP now owns 2,615,369 shares of the company’s stock worth $4,132,000 after purchasing an additional 32,879 shares in the last quarter. Finally, Geode Capital Management LLC increased its stake in shares of Apyx Medical by 7.5% in the fourth quarter. Geode Capital Management LLC now owns 352,809 shares of the company’s stock worth $558,000 after purchasing an additional 24,596 shares in the last quarter. 55.33% of the stock is owned by hedge funds and other institutional investors.

Apyx Medical Stock Performance

Shares of NASDAQ APYX opened at $0.90 on Thursday. The firm has a fifty day moving average price of $1.26 and a 200-day moving average price of $1.37. The company has a debt-to-equity ratio of 3.03, a current ratio of 5.46 and a quick ratio of 4.52. The stock has a market cap of $34.01 million, a PE ratio of -1.08 and a beta of 0.92. Apyx Medical Co. has a 1 year low of $0.76 and a 1 year high of $1.99.

Apyx Medical (NASDAQ:APYX) last announced its quarterly earnings data on Thursday, March 13th. The company reported ($0.12) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.13) by $0.01. The firm had revenue of $14.22 million during the quarter, compared to analysts’ expectations of $13.39 million. Apyx Medical had a negative net margin of 58.59% and a negative return on equity of 137.98%. Equities analysts anticipate that Apyx Medical Co. will post -0.68 earnings per share for the current fiscal year.

About Apyx Medical

Apyx Medical Corporation, an energy technology company, engages in the design, development, and manufacture of medical devices in the United States and internationally. The company operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures.